00:21:12 EDT Tue 30 Apr 2024
Enter Symbol
or Name
USA
CA



Q:TRIB - TRINITY BIOTECH PLC SPON ADR EACH REP 20 ORD (POST SPLIT) - http://www.trinitybiotech.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
TRIB - Q0.51.77·2.040.11.78-0.05-2.710.517351.80  1.9696  1.785.50  1.7916:00:00Apr 0415 min RT 2¢

Recent Trades - Last 10 of 35
Time ETExPriceChangeVolume
16:00:00Q1.78-0.051
15:59:18Q1.78-0.05200
15:51:38Q1.79-0.0477
15:33:36Q1.79-0.0423
15:07:10Q1.80-0.03200
15:04:06Q1.80-0.0341
15:02:45Q1.80-0.03200
15:02:25Q1.82-0.01100
15:02:25Q1.82-0.01200
15:02:25Q1.82-0.01100

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-04-04 07:30U:TRIBNews ReleaseTrinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business Updates
2024-03-28 18:39U:TRIBNews ReleaseTrinity Biotech plc to Announce Q4 and Fiscal Year 2023 Financial Results
2024-03-08 10:04U:TRIBNews ReleaseTrinity Biotech Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
2024-02-15 12:35U:TRIBNews ReleaseTrinity Biotech Plc Finalizes Effective Date of ADS Ratio Change
2024-02-13 09:00U:TRIBNews ReleaseTrinity Biotech Plc Announces Plan to Implement ADS Ratio Change
2024-02-08 08:30U:TRIBNews ReleaseTrinity Biotech to Present at Emerging Growth Conference
2024-02-07 08:30U:TRIBNews ReleaseTrinity Biotech Announces Application for Early Sjogrens Syndrome Test Panel PLA Code
2024-01-31 07:05U:TRIBNews ReleaseTrinity Biotech Announces Q3 2023 Financial Results & Business Update
2024-01-31 07:02U:TRIBNews ReleaseTrinity Biotech Announces Entry into a Letter of Intent with Bayer for a Joint Partnership to Launch a CGM Biosensor Device in China and India
2024-01-31 07:00U:TRIBNews ReleaseTrinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.
2024-01-30 17:24U:TRIBNews ReleaseTrinity Biotech plc to Host Investor Call
2023-12-27 08:58U:TRIBNews ReleaseTrinity Biotech Announces It Has Begun Shipments of Its New HIV Screening Test, TrinScreen HIV to Kenya
2023-12-18 16:30U:TRIBNews ReleaseTrinity Biotech Announces Management Changes
2023-11-28 16:06U:TRIBNews ReleaseTrinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares
2023-10-10 08:16U:TRIBNews ReleaseTrinity Biotech Welcomes The Decision Of The High Court Of Kenya To Strike Out The Applications To Prevent the Procurement of TrinScreen HIV By The Kenyan Ministry of Health
2023-10-03 09:15U:TRIBNews ReleaseTrinity Biotech Announces Q2 2023 Financial Results
2023-09-27 12:50U:TRIBNews ReleaseTrinity Biotech plc to Announce Second Quarter Fiscal Year 2023 Financial Results
2023-09-11 16:50U:TRIBNews ReleaseTrinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Minimum Bid Price Requirement
2023-08-07 08:01U:TRIBNews ReleaseTrinity Biotech Announces That It Has Received 510(k) Clearance From The U.S. Food and Drug Administration for the Premier Resolution System
2023-07-06 09:45U:TRIBNews ReleaseTrinity Biotech Announces Q1 2023 Financial Results